| Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation Z Yang, J Shi, J Xie, Y Wang, J Sun, T Liu, Y Zhao, X Zhao, X Wang, Y Ma, ... Nature biomedical engineering 4 (1), 69-83, 2020 | 484 | 2020 |
| Combining immunotherapy and radiotherapy for cancer treatment: current challenges and future directions Y Wang, W Deng, N Li, S Neri, A Sharma, W Jiang, SH Lin Frontiers in pharmacology 9, 185, 2018 | 344 | 2018 |
| Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity CA von Roemeling, Y Wang, Y Qie, H Yuan, H Zhao, X Liu, Z Yang, ... Nature communications 11 (1), 1508, 2020 | 166 | 2020 |
| Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy H Yuan, W Jiang, CA Von Roemeling, Y Qie, X Liu, Y Chen, Y Wang, ... Nature nanotechnology 12 (8), 763-769, 2017 | 148 | 2017 |
| The reciprocity between radiotherapy and cancer immunotherapy Y Wang, ZG Liu, H Yuan, W Deng, J Li, Y Huang, BYS Kim, MD Story, ... Clinical Cancer Research 25 (6), 1709-1717, 2019 | 107 | 2019 |
| Low-dose anti-angiogenic therapy sensitizes breast cancer to PD-1 blockade Q Li, Y Wang, W Jia, H Deng, G Li, W Deng, J Chen, BYS Kim, W Jiang, ... Clinical Cancer Research 26 (7), 1712-1724, 2020 | 97 | 2020 |
| Tumor vasculatures: a new target for cancer immunotherapy Z Liu, Y Wang, Y Huang, BYS Kim, H Shan, D Wu, W Jiang Trends in pharmacological sciences 40 (9), 613-623, 2019 | 92 | 2019 |
| Therapeutic remodeling of the tumor microenvironment enhances nanoparticle delivery Y Chen, X Liu, H Yuan, Z Yang, CA von Roemeling, Y Qie, H Zhao, ... Advanced Science 6 (5), 1802070, 2019 | 92 | 2019 |
| Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles X Li, S Khorsandi, Y Wang, J Santelli, K Huntoon, N Nguyen, M Yang, ... Nature nanotechnology 17 (8), 891-899, 2022 | 85 | 2022 |
| Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling N Li, Y Wang, S Neri, Y Zhen, LWR Fong, Y Qiao, X Li, Z Chen, C Stephan, ... Nature communications 10 (1), 4363, 2019 | 76 | 2019 |
| Considerations for designing preclinical cancer immune nanomedicine studies W Jiang, Y Wang, JA Wargo, FF Lang, BYS Kim Nature nanotechnology 16 (1), 6-15, 2021 | 74 | 2021 |
| Immunocyte membrane-coated nanoparticles for cancer immunotherapy P Gong, Y Wang, P Zhang, Z Yang, W Deng, Z Sun, M Yang, X Li, G Ma, ... Cancers 13 (1), 77, 2020 | 53 | 2020 |
| Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy Y You, Y Tian, Z Yang, J Shi, KJ Kwak, Y Tong, AP Estania, J Cao, ... Nature biomedical engineering 7 (7), 887-900, 2023 | 48 | 2023 |
| Intelligent photothermal dendritic cells restart the cancer immunity cycle through enhanced immunogenic cell death Z Sun, G Deng, X Peng, X Xu, L Liu, J Peng, Y Ma, P Zhang, A Wen, ... Biomaterials 279, 121228, 2021 | 46 | 2021 |
| Harnessing innate immunity using biomaterials for cancer immunotherapy DY Lee, K Huntoon, Y Wang, W Jiang, BYS Kim Advanced Materials 33 (27), 2007576, 2021 | 45 | 2021 |
| Folate receptor-targeted albumin nanoparticles based on microfluidic technology to deliver cabazitaxel F Meng, Y Sun, RJ Lee, G Wang, X Zheng, H Zhang, Y Fu, G Yan, Y Wang, ... Cancers 11 (10), 1571, 2019 | 40 | 2019 |
| Survival patterns for patients with resected N2 non–small cell lung cancer and postoperative radiotherapy: a prognostic scoring model and heat map approach W Deng, T Xu, Y Xu, Y Wang, X Liu, Y Zhao, P Yang, Z Liao Journal of Thoracic Oncology 13 (12), 1968-1974, 2018 | 38 | 2018 |
| Mutant LKB1 confers enhanced radiosensitization in combination with trametinib in KRAS-mutant non–small cell lung cancer Y Wang, N Li, W Jiang, W Deng, R Ye, C Xu, Y Qiao, A Sharma, M Zhang, ... Clinical Cancer Research 24 (22), 5744-5756, 2018 | 38 | 2018 |
| Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer W Deng, T Xu, Y Wang, Y Xu, P Yang, D Gomez, Z Liao Lung Cancer, 2018 | 37 | 2018 |
| Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy C Xu, L Guo, Z Liao, Y Wang, X Liu, S Zhao, J Wang, Z Yuan, P Wang, ... Clinical and Translational Radiation Oncology 17, 17-23, 2019 | 35 | 2019 |
Wen JiangUniversity of Texas MD Anderson Cancer CenterПодтвержден адрес электронной почты в домене mdanderson.org
